TFChem Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Debt
  • Financing Rounds
  • 3

TFChem General Information

Description

Developer of carbohydrate based drugs. The company is mainly engaged in drug discovery using fluorine atom properties to develop new glycomimetic compounds for the treatment of diabetes and obesity, enabling healthcare practitioners to use the compounds in various applications, such as cancer, diabetes, pain and inflammation and cardio-vascular diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Parent Company
Primary Office
  • Voie de l'innovation
  • Pharma Parc II Chaussée du Vexin
  • 27100 Val de Reuil
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TFChem Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TFChem‘s full profile, request access.

Request a free trial

TFChem Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TFChem‘s full profile, request access.

Request a free trial